Clariant

Clariant signs long-term joint development and commercialization agreements with Lummus Novolen Technology on polypropylene catalyst

  • Enhanced polypropylene catalyst technology by joint R&D
  • Polypropylene catalyst commercialization agreement with major polypropylene technology licensor Lummus Novolen Technology
  • Joint investment of CHF 65 million into new polypropylene catalyst plant

Muttenz, August 22, 2013 - Clariant, a world leader in specialty chemicals, today announced that its Business Unit Catalysts has signed long-term cooperation agreements with CB&I's Lummus Novolen Technology GmbH business unit. The two companies will combine and ramp up R&D efforts to develop improved polypropylene catalyst and donor technologies. When successful, existing and future Lummus Novolen licensees and other polypropylene producers will be supplied with the new catalyst developed by a new state-of-the-art Ziegler-Natta polypropylene catalyst production line.

Clariant and Lummus Novolen will jointly invest about CHF 65 million in this new state-of-the-art polypropylene catalyst production line at Clariant’s catalyst production hub in Louisville, Kentucky, USA. The plant is expected to be on stream in 2015.

By leveraging the successful licensing and process design experience of Lummus Novolen and the strong catalyst R&D capabilities of Clariant, the two companies expect to further strengthen their joint position in polypropylene catalyst. The polypropylene Ziegler-Natta catalyst market is expected to continue the high growth pace shown over the last decade with estimated growth rates of more than five percent in the next five years.

Hariolf Kottmann, CEO of Clariant, stated: “The strategic partnership with Lummus Novolen is a significant milestone for the catalyst business. It strengthens our competitive position in a market with future perspectives and strong growth rates. This cooperation is another example for the successful implementation of Clariant’s strategy which is focused on innovation, portfolio management and profitable growth.”

"This alliance between Lummus Novolen and Clariant in the field of polypropylene catalyst will strengthen the innovation potential to better serve the needs of our clients. The state-of-the-art catalyst production plant will guarantee continuous supply and consistent product quality,” said Daniel McCarthy, Executive Vice President and President of CB&I’s Technology operating group. “With this new direction, the Lummus Novolen technology portfolio will become an even more attractive offer to the growing polypropylene market."

Reader enquiries

Clariant International Ltd
Rothausstrasse 61
4132 Muttenz 1
Switzerland

+41 61 469 6742

www.clariant.com

@clariant

Clariant

ClariantInternational

clariant_international


Notes for editors


www.clariant.com

Clariant is a globally leading specialty chemicals company, based in Muttenz near Basel/Switzerland. On December 31, 2012 the company employed a total workforce of 21,202. In the financial year 2012, Clariant recorded sales of CHF 6.038 billion for its continuing businesses. The company reports in four business areas: Care Chemicals, Catalysis & Energy, Natural Resources, Plastics & Coatings. Clariant’s corporate strategy is based on four pillars: managing businesses for profitability, research & development and innovation, growth in emerging markets, and repositioning of the portfolio.

www.CBI.com

CB&I (NYSE:CBI) is the most complete energy infrastructure focused company in the world and a major provider of government services. Drawing upon more than a century of experience and the expertise of approximately 50,000 employees, CB&I provides reliable solutions while maintaining a relentless focus on safety and an uncompromising standard of quality. For more information, visit www.cbi.com.

www.novolentechnology.com

Lummus Novolen Technology’s total licensed polypropylene capacity is currently more than 9.5 million metric tons per year. Upcoming projects based on Novolen polypropylene technology include the expansion of two Novolen-based plants in China currently in operation, two new plants in India, and one each in China, Russia and Kazakhstan.

Editorial enquiries

Kai Rolker
Clariant International Ltd

+41 61 469 6363

kai.rolker@​clariant.com

Stefanie Nehlsen
Clariant International Ltd

+41 61 469 63 63

stefanie.nehlsen@​clariant.com

Ulrich Steiner
Investor Relations
Clariant International Ltd

+41 61 469 6745

Ulrich.Steiner@​Clariant.com

Siegfried Schwirzer
Investor Relations
Clariant International Ltd

+41 61 469 6749

siegfried.schwirzer@​clariant.com

 

Also available in

 

Share

 

More news from